Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Solitary Fibrous Tumors 1Sarcoma 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Granuloma, Plasma Cell 1Glioma 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Metformin 21Inositol 14Letrozole 9Exercise 5Surveys and Questionnaires 4Clomiphene 4Tablets 3Estradiol 3semaglutide 2maltodextrin 2drospirenone and ethinyl estradiol combination 2Spironolactone 2Progesterone 2Ethinyl Estradiol 2Diet Therapy 2Contraceptives, Oral, Combined 2Caloric Restriction 2Acupuncture Therapy 2mirabegron 1etonogestrel 1drospirenone 1dapagliflozin 1cetrorelix 1Walking 1Tirzepatide 1Thyroxine 1Thioctic Acid 1Tamoxifen 1Sodium-Glucose Transporter 2 Inhibitors 1Sex Characteristics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Capsules × 1 year × Clear all
NCT07182526 2025-09-19

Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome

Al-Mustansiriyah University

Phase 2 Recruiting
150 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡